Northwestern Mutual Wealth Management CO Viking Therapeutics, Inc. Transaction History

Northwestern Mutual Wealth Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$9.24 - $19.64 $12,825 - $27,260	1,388 New	1,388 $25,000
Q4 2021 Feb 03, 2022	BUY	$4.6 - $6.72 $2,530 - $3,696	550 New	550 $3,000
Q4 2020 Feb 12, 2021	SELL	$5.3 - $6.71 $1,590 - $2,013	-300 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$5.73 - $8.11 $1,719 - $2,433	300 New	300 $2,000
Q2 2020 Aug 14, 2020	SELL	$4.35 - $8.08 $252 - $468	-58 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$3.45 - $7.95 $200 - $461	58 New	58 $0
Q2 2019 Aug 12, 2019	SELL	$7.67 - $10.63 $582 - $807	-76 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$7.58 - $9.94 $576 - $755	76 New	76 $1,000

442

63.3M

6.23M

2.97M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.83B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.